Skip to main content

BMY - Bristol-Myers Squibb Co

This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.

In Q1 2020 it was held by 11 managers with an aggregate reported value of $2.23B, which is 0.31% of the combined portfolio.

As of Q1 2020, 11 tracked institutional managers held BMY (Bristol-Myers Squibb Co) with an aggregate reported value of $2.23B0.31% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades BMY sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q1 2020
Ticker
BMY

13F data is delayed and excludes shorts/non-13F assets.

Holders

1Dodge & Cox - Dodge & Cox2.19%Reduce -27.8%36,277,074$2.02B
2Richard Pzena - Pzena Investment Management0.77%Reduce -27.6%1,836,457$102.36M
3Kahn Brothers Group - Kahn Brothers Group10.46%Reduce -2.6%1,026,209$57.2M
4David Rolfe - Wedgewood Partners2.74%New259,180$14.45M
5Torray Funds - Torray Funds2.07%New167,775$9.35M
6Mairs & Power Growth Fund - Mairs & Power Growth Fund0.12%Reduce -33.2%148,613$8.28M
7Ariel Investments - Ariel Investments0.13%New134,506$7.5M
8Hillman Value Fund - Hillman Value Fund4.53%Reduce -2.0%84,930$4.73M
9Lee Ainslie - Maverick Capital0.08%Reduce -40.2%68,953$3.84M
10Jensen Investment Management - Jensen Investment Management0.02%-27,175$1.52M
11David Katz - Matrix Asset Advisors0.14%Reduce -9.1%10,636$593K
Loading holder history for BMY